中证科创创业创新药指数和中证科创创业医疗器械指数将在11月7日发布

Core Insights - The announcement by China Securities Index Co., Ltd. regarding the launch of the CSI Innovation Drug Index and the CSI Medical Device Index on November 7, 2025, aims to provide a broader range of investment options for the market [1]. Group 1: Index Details - The CSI Innovation Drug Index will select listed companies from the Sci-Tech Innovation Board and the ChiNext Board that are involved in innovative drug research and development, as well as those providing research, development, and production services for pharmaceutical companies [1]. - The CSI Medical Device Index will include listed companies from the same boards that offer medical devices, medical consumables, and in vitro diagnostic products and services [1]. Group 2: Market Impact - These indices are designed to reflect the overall performance of listed companies in the innovative drug and medical device sectors within the Sci-Tech Innovation Board and ChiNext Board [1].